UBS analyst Kevin McVeigh raised the firm’s price target on Accenture (ACN) to $320 from $315 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture: Resilient Execution, AI-Driven Growth, and Margin Durability Support Buy Rating Despite Share Weakness
- Accenture Earnings Call Highlights AI-Led Growth Momentum
- Accenture to explore partnerships with DOE to support Genesis Mission
- Accenture price target raised to $300 from $280 at Evercore ISI
- Accenture price target raised to $300 from $270 at BMO Capital